Hagen Cramer
Company: QurAlis Corp.
Job title: Chief Technology Officer
Seminars:
Critical Process Parameters in Oligonucleotide Manufacturing: Strategies for Control During Scale-Up 3:00 pm
• Emphasizing the importance of early identification of Critical Process Parameters (CPP) to enable effective control strategies that ensure consistent product quality and compliance • Developing robust and predictive down-scale models to accurately illustrate large scale manufacturing and minimize risk of unexpected results during scale up • Case studies highlighting the impact of insufficient CPP…Read more
day: Day One PM
Panel Discussion: Lowering the Barrier to Entry for Oligonucleotide Drug Development 1:30 pm
• How can companies in the oligo space collaborate to ease entry for small biotechs • Exploring attempts to lower costs of analytical development and manufacturing and their subsequent impacts • Balancing innovation of analytical methods and technology versus cost- saving practises Read more
day: Day Two PM
Panel Discussion: Exploring Novel Oligonucleotide Drug Development: Unlocking New Opportunities, Overcoming Market Challenges & Advancing Innovative Oligos Through Pipelines 8:30 am
• Validating strengths and new opportunities that have emerged in the space • Analyzing weaknesses and threats that oppose commercial market access • Overview of different oligo modalities and their positioning in clinical development Read more
day: Day One AM
Chairs Closing Remarks & End of Conference Day One 5:00 pm
day: Day One PM